Mumbai-based D2C health-focused brand, The Good Bug has raised $3.5 million in series A funding led by Fireside Ventures. A large part of this fund will be deployed for new product development, team expansion, and brand investment, a statement issued by the company said.
"In a short span of time, we have identified the importance of Gut Health early on and delivered the consumer promise through scientifically backed and user-friendly solutions. The brand's dedication to demystifying the complexities of gut health and making it accessible to all is witnessing widespread recognition and trust from consumers," it said.
The brand addresses chronic issues across bloating, constipation, weight management others through the gut.
Commenting on the capital infusion, Keshav Biyani and Prabhu Karthikeyan, founders of The Good Bug Said, " We aim to pioneer and expand the Gut Health category in India, which has been an unexplored segment. We’re unraveling the same by helping people get to the root cause of core health issues and holistically solve them. Our journey has been about more than just business; it's about transforming lives. We are thrilled to see the impact we've had on people's health and well-being. We are excited to have Fireside Ventures as our partner in this journey, with their deep knowledge of the Indian consumer start-up eco-system.”
Ankur Khaitan, principal of Fireside Ventures, said, "As consumers are getting more health-conscious and looking for safe and effective solutions with long-term benefits; we see a huge potential for gut health. The Good Bug is at the forefront of this segment with its innovative and effective products. We are thrilled to partner with the team as they continue to pursue their vision.”
Set up in November 2022, the brand is serving over 1 lakh+ customers and counting. Offering easy-to-use and effective products, it has established category leadership in gut health and aims to pioneer and create this market in India. The brand has also been backed by Think9 Consumer Technologies.